CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding CervoMed Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 11 | 1 | 12 | +2 |
| Shares | 176.7K | 9 | 363.7K | +187.0K (+105.8%) |
| Value | $589.9K | $30 | $1.68M | +$1.09M (+185.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held CervoMed Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 199,347 | $921.0K | 0.00% |
| Rock Springs Capital Management LP | 80,033 | $369.8K | 0.01% |
| Hoey Investments, Inc | 1,080 | $4.99K | 0.00% |
| Citigroup Inc | 1 | $5 | 0.00% |
Sold out (2)
Institutions that held CervoMed Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 16,565 | $55.0K |
| UBS Group AG | 60 | $200 |
Not filed for Q3 2023 yet (1)
Institutions that held CervoMed Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coastal Capital Group, Inc. | 9 | $30 |